Copenhagen, Denmark, February 1, 2021 - Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 ('Orphazyme'), hereby notifies receipt of information of the following transactions in Orphazyme's shares by persons discharging managerial responsibilities in Orphazyme:
1Details of the Reporting Person /Closely Associated Person
a) Name
Anders Vadsholt
2Reason for the notification
a) Position/status
Chief Financial Officer
b) Initial notification/Amendment
Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Orphazyme A/S
b) LEI code
54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code
Shares
ISIN DK0060910917
b) Nature of the transaction
Vesting of Matching Shares
c) Price(s) and volume(s)
Price(s)
Volume(s)
DKK
1
17,561
d) Aggregated information
Aggregated volume: 17,561 shares
Aggregated price: DKK 17,561.00
Price per share (volume weighted average): DKK 1
e) Date of the transaction
February 1, 2021
f) Place of the transaction
Outside a trading venue
Attachments
- Original document
- Permalink
Disclaimer
Orphazyme A/S published this content on 01 February 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 February 2021 21:34:02 UTC.